|
05.09.2024 18:00:00
|
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
COPENHAGEN, Denmark, September 5, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such.
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Paul John Chaplin | |
| 2. | Reason for the notification | ||
| a) | Position/status | President and Chief Executive Officer of Bavarian Nordic A/S | |
| b) | Initial notification/Amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Bavarian Nordic A/S | |
| b) | LEI | 2138006JCDVYIN6INP51 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Shares DK0015998017 | |
| b) | Nature of the transaction | Exercise of warrants | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 146.60 | 98,855 | ||
| d) | Aggregated information
| 98,855 DKK 14,492,143.00 | |
| e) | Date of the transaction | 2024-09-05 | |
| f) | Place of the transaction | Nasdaq Copenhagen A/S, XCSE | |
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Henrik Juuel | |
| 2. | Reason for the notification | ||
| a) | Position/status | Executive Vice President and Chief Financial Officer of Bavarian Nordic A/S | |
| b) | Initial notification/Amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Bavarian Nordic A/S | |
| b) | LEI | 2138006JCDVYIN6INP51 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Shares DK0015998017 | |
| b) | Nature of the transaction | Exercise of warrants | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 146.60 | 42,916 | ||
| d) | Aggregated information
| 42,916 DKK 6,291,486.00 | |
| e) | Date of the transaction | 2024-09-05 | |
| f) | Place of the transaction | Nasdaq Copenhagen A/S, XCSE | |
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Jean-Christophe May | |
| 2. | Reason for the notification | ||
| a) | Position/status | Executive Vice President and Chief Commercial Officer of Bavarian Nordic A/S | |
| b) | Initial notification/Amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Bavarian Nordic A/S | |
| b) | LEI | 2138006JCDVYIN6INP51 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Shares DK0015998017 | |
| b) | Nature of the transaction | Exercise of warrants | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 155.80 | 7,039 | ||
| d) | Aggregated information
| 7,039 DKK 1,096,676.00 | |
| e) | Date of the transaction | 2024-09-05 | |
| f) | Place of the transaction | Nasdaq Copenhagen A/S, XCSE | |
About Bavarian Nordic
Bavarian Nordic is a fully integrated vaccine company with a mission to protect and save lives through innovative vaccines. We are a global leader in smallpox and mpox vaccines, supplied to governments to enhance public health preparedness and have a strong portfolio of vaccines for travelers and endemic diseases. For more information visit www.bavarian-nordic.com.
Contacts
Europe: Rolf Sass Sørensen, Vice President Investor Relations, rss@bavarian-nordic.com, Tel: +45 61 77 47 43
US: Graham Morrell, Paddock Circle Advisors, graham@paddockcircle.com, Tel: +1 781 686 9600
Company Announcement no. 28 / 2024
Attachment
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Bavarian Nordic A/Smehr Nachrichten
|
14.11.24 |
Ausblick: Bavarian Nordic stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) | |
|
31.10.24 |
Erste Schätzungen: Bavarian Nordic vermeldet Zahlen zum jüngsten Quartal (finanzen.net) | |
|
13.09.24 |
WHO segnet erstmals Mpox-Impfstoff ab (dpa-AFX) | |
|
29.08.24 |
MPox: Affenpocken-Impfstoff-Lieferungen von Bavarian Nordic in den Kongo verzögern sich (Spiegel Online) | |
|
26.08.24 |
Deutschland spendet Mpox-Impfstoff an betroffene Länder (dpa-AFX) | |
|
22.08.24 |
Bavarian Nordic: Das Unternehmen, das die Welt mit Mpox-Impfstoff versorgen soll (Spiegel Online) | |
|
22.08.24 |
Bavarian Nordic-Aktie nach starken Gewinnzahlen im Höhenrausch (finanzen.at) | |
|
22.08.24 |
Ausblick: Bavarian Nordic legt Quartalsergebnis vor (finanzen.net) |
Analysen zu Bavarian Nordic A/Smehr Analysen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.